Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

REPH

Recro Pharma (REPH)

Recro Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REPH
DateTimeSourceHeadlineSymbolCompany
06/06/20233:38PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
06/02/20233:32PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/26/20233:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
05/22/20234:11PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:REPHRecro Pharma Inc
05/19/20233:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20233:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20233:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20233:57PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20233:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/19/20233:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
05/18/20234:00PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
05/10/20233:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
05/03/20233:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
04/06/20237:26AMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:REPHRecro Pharma Inc
03/24/20233:07PMEdgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:REPHRecro Pharma Inc
03/24/20233:05PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
03/13/20236:40AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
03/01/20234:01PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
03/01/20233:58PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:REPHRecro Pharma Inc
03/01/20233:52PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:REPHRecro Pharma Inc
03/01/20233:29PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
02/14/20231:58PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/10/20238:09AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
02/02/20234:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
01/20/20233:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
01/05/20233:33PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:REPHRecro Pharma Inc
01/05/20233:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REPHRecro Pharma Inc
01/03/20233:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
12/20/20223:56PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REPHRecro Pharma Inc
12/16/20224:01PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REPHRecro Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:REPH